Infections in out-of-hospital and in-hospital post-cardiac arrest patients.


Journal

Internal and emergency medicine
ISSN: 1970-9366
Titre abrégé: Intern Emerg Med
Pays: Italy
ID NLM: 101263418

Informations de publication

Date de publication:
06 2020
Historique:
received: 26 09 2019
accepted: 24 01 2020
pubmed: 14 2 2020
medline: 11 2 2021
entrez: 14 2 2020
Statut: ppublish

Résumé

This study aims to describe infectious complications in both out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest (IHCA) patients with sustained return of spontaneous circulation (ROSC) and to compare differences in antimicrobial treatment and outcomes between the two groups. This was a retrospective, single-center, observational study. Adult patients (≥ 18 years) with OHCA or IHCA who had sustained ROSC between December 2007 to March 2015 were included. Blood, urine, sputum, and other fluid cultures, as well as radiologic imaging, were obtained at the discretion of the treating clinical teams. 275 IHCA and 318 OHCA patients were included in the analysis. We found evidence of infection in 181 IHCA and 168 OHCA patients. Significant differences were found between the IHCA and OHCA group in terms of initial rhythm, duration of arrest (10 min vs. 20, p = < 0.001), targeted temperature management (30% vs. 73%, p = < 0.001), and post-arrest infection rates (66% vs 53%, p = 0.001). 95% of IHCA and 82% of OHCA patients received antimicrobial treatment in the post-cardiac arrest period. The source of infection in both groups was largely respiratory, followed by urinary. Gram-positive cocci and gram-negative rods were the most common organisms identified among subjects with culture-proven bacteremia. Infections in the post-arrest period were common in both OHCA and IHCA. We found significantly more infections in IHCA compared to OHCA patients. The most common infection category was respiratory and the most common organism isolated from sputum cultures was Staphylococcus aureus coagulase-positive. The incidence of culture-positive bacteremia was similar in both OHCA and IHCA cohorts but overall lower than previously reported.

Identifiants

pubmed: 32052366
doi: 10.1007/s11739-020-02286-3
pii: 10.1007/s11739-020-02286-3
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

701-709

Commentaires et corrections

Type : CommentIn

Auteurs

Sharri Junadi Mortensen (SJ)

Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA. smortens@bidmc.harvard.edu.

Meredith Hurley (M)

Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.

Lauren Blewett (L)

Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.

Amy Uber (A)

Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.

David Yassa (D)

Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Mary MacDonald (M)

Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.

Parth Patel (P)

Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.

Maureen Chase (M)

Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.
Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Mathias Johan Holmberg (MJ)

Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.
Department of Clinical Medicine, Research Center for Emergency Medicine, Aarhus University Hospital, Århus, Denmark.

Anne Victoria Grossestreuer (AV)

Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.

Michael William Donnino (MW)

Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.
Division of Pulmonary Critical Care, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Michael Noel Cocchi (MN)

Center for Resuscitation Science, Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.
Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Division of Critical Care, Department of Anesthesia Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH